Literature DB >> 12927684

An ELISA for the detection of TIMP-1 based on recombinant single chain Fv fusion proteins.

Gordana Wozniak1, Eva Obermayr, Matjaz Jeras, Mio Knezevic, Florian Rüker.   

Abstract

BACKGROUND: Altered serum levels of TIMP-1 are an indicator of various pathological states. To quantitate TIMP-1 in biological samples, we have previously isolated TIMP-1 specific single-chain Fv fragments (scFvs) using phage-display. In the work presented here, we have used these scFvs to establish a TIMP-1 ELISA based exclusively on recombinant scFv fusion proteins.
METHODS: Two distinct TIMP-1 specific scFvs were used as the antigen binding components after being genetically fused to the N-termini of two different fusion protein constructs. One fusion protein, comprising a CL domain, serves as a coating reagent, while the second fusion protein with a modified form of bacterial alkaline phosphatase is used as a detection reagent. A double antibody sandwich-ELISA was then established and optimized.
RESULTS: An ELISA for the quantitation of tissue inhibitor of metalloproteinase (TIMP)-1, based entirely on recombinant antibody fragments, was developed as an alternative to assays using polyclonal antisera or monoclonal antibodies. Its performance was shown to compare well with a conventional ELISA. Finally, TIMP-1 concentrations in the sera of sixty healthy individuals were determined.
CONCLUSION: The assay described here provides a standardized, reliable and readily available means of quantitation of TIMP-1 in a large number of blood samples.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12927684     DOI: 10.1016/s0009-8981(03)00281-x

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  1 in total

1.  Production and characterization of a single-chain Fv antibody-alkaline phosphatase fusion protein specific for clenbuterol.

Authors:  Xixia Liu; Hong Wang; Yan Liang; Jinyi Yang; Hongbin Zhang; Hongtao Lei; Yudong Shen; Yuanming Sun
Journal:  Mol Biotechnol       Date:  2010-05       Impact factor: 2.695

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.